IDOX PLC

Director's Dealing • Apr 5, 2022

National Storage Mechanism | Additional information

RNS Number : 2294H

IDOX PLC

05 April 2022

5 April 2022

Idox plc 

("Idox", "the Company" or "the Group")

Director/PDMR Shareholding

Idox plc (AIM: IDOX), a leading supplier of specialist information management software and solutions to the public and asset intensive sectors, announces that, on 4 April 2022, David Meaden, Chief Executive Officer of the Company, has exercised options under the 2019 Idox plc Long Term Incentive Plan over a total of 3,512,400 ordinary shares of 1p each ("Ordinary Shares").

The Company also announces that, on the same day, Mr Meaden sold 2,870,000 Ordinary Shares at a price of 60.93 pence per share partially to satisfy current tax liabilities relating to option exercises over Ordinary Shares.

Following this notification, Mr Meaden has a beneficial holding of 1,110,539 Ordinary Shares (which represents 0.24% of the issued share capital of the Company).

Applications have been made for the 3,512,400 new Ordinary Shares to be admitted to trading on AIM ("Admission"). It is expected that Admission will occur at 8.00 a.m. on or around 8 April 2022.

The total number of Ordinary Shares in issue following Admission will be 451,047,104. The Company holds 1,426,219 Ordinary Shares in treasury. Therefore the total number of Ordinary Shares with voting rights in the Company will be 449,620,885.

The above figure of 449,620,885 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.

The information below (set out in accordance with the requirements of EU Market Abuse Regulation) provides further detail:

1.         

Details of the person discharging managerial responsibilities / person closely associated

a.         

Name

David Meaden

2.         

Reason for the notification

a.         

Position/status

Chief Executive Officer

b.         

Initial notification

/Amendment

Initial Notification

3.         

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.         

Name

Idox plc

b.         

LEI

213800Z3FE6PWVSUGE70

4.         

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

b.         

Nature of the transaction

1.    Exercise of options over Ordinary Shares

2.    Sale of Ordinary Shares.

c.         

Price(s) and volume(s)

	Price(s)	Volume(s)
1.	n/a	3,512,400
2.	60.93p	2,870,000

d.         

Aggregated information

·    Aggregated volume

·     Price 

	Price(s)	Volume(s)
1.	n/a	3,512,400
2.	£1,748,691.00	2,870,000

e.         

Date of the transaction

1.    4 April 2022

2.    4 April 2022

f.         

Place of the transaction

1.    Outside a trading venue

2.    London Stock Exchange (XLON); AIM

For further information please contact:

Idox plc  Chris Stone, Non-Executive Chairman David Meaden, Chief Executive Anoop Kang, Chief Financial Officer	+44 (0) 870 333 7101
Peel Hunt LLP (NOMAD and Broker) Edward Knight Paul Gillam James Smith	+44 (0) 20 7418 8900
MHP Communications   Reg Hoare                                                         James Bavister	+ 44 (0) 203 128 8793 idox@mhpc.com

About Idox plc

For more information see www.idoxplc.com @Idoxgroup 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHFLFVASIISIIF